Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
March 19, 2019

Genentech gets FDA nod for Tecentriq plus chemotherapy to treat ES-SCLC

Roche Group member Genentech has secured approval from the US Food and Drug Administration (FDA) for its Tecentriq (atezolizumab) in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer (ES-SCLC).

Continue
Image: Genentech in South San Francisco, US. Photo: courtesy of F. Hoffmann-La Roche Ltd.
March 18, 2019

Study finds widely used heart drug increases risk of sudden cardiac arrest

Image: Study reveals commonly used heart drug associated with increased risk of sudden cardiac arrest. Photo: courtesy of Pexels/Pixabay.
March 18, 2019

Blackstone to buy Japanese specialty pharmaceutical firm Ayumi

Image: Blackstone has agreed to acquire Japanese specialty pharmaceutical firm Ayumi. Photo: courtesy of Aleš Čerin / FreeImages.

Contracts

March 11, 2019

TaiwanJ Pharmaceuticals out-licenses liver drug candidate in Asia

Image: TaiwanJ Pharmaceuticals obtained $26m deal for licensing and co-development contract with Newsoara Biopharma on JKB-122 Asian rights. Photo: courtesy of rawpixel/Unsplash.com.

GeoVax, Leidos expand collaboration to malaria vaccines

World’s largest pharmaceutical firm selects ValGenesis to standardize corporate validation process enterprise-level

Amprologix wins DHSC backing for new antibiotic

Deals

Deals March 13, 2019

Fujifilm to buy Biogen’s Danish biologics manufacturing site for $890m

Pharmaceutical Business Review

Ligand sells Promacta assets and Royalty for $827m

Biogen to acquire UK-based Nightstar Therapeutics for $877m

Sagent Pharmaceuticals announces acquisition of Raleigh manufacturing site

Popular

  1. Imara closes $63m Series B cross-over financing
  2. Biohaven enrolls first patient in phase 3 Spinocerebellar Ataxia clinical trial of Troriluzole
  3. European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
  4. FDA approves Dupixent for moderate-to-severe atopic dermatitis in adolescents
  5. Lilly’s CYRAMZA meets primary endpoint in phase 3 RELAY trial

PRESS RELEASES

EPSILON 1: The Next Generation
EPSILON 1: The Next Generation
Upcoming Complimentary Webinar from NSF
Upcoming Complimentary Webinar from NSF
Sieving Technologies for Pharma Powders
Sieving Technologies for Pharma Powders
Tosoh Bioscience Introduces TSKgel® FcR-IIIA-NPR Columns
Tosoh Bioscience Introduces TSKgel® FcR-IIIA-NPR Columns
PBL Takes On Its First Apprentice
PBL Takes On Its First Apprentice

Suppliers

Whitepapers

XRF In the Hands of Scientists
XRF In the Hands of Scientists
EPSILON 1 – Focus on the Details to Capture the Bigger Picture
EPSILON 1 – Focus on the Details to Capture the Bigger Picture
EPSILON 1 – Small and Powerful
EPSILON 1 – Small and Powerful